{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#33 - Marcio Souza, CEO of Praxis Precision Medicines","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a6a81a02\"></iframe>","width":"100%","height":180,"duration":877,"description":"Join us on the latest episode! Our Guest: Marcio Souza, CEO of Praxis Precision Medicines.\nWhat you'll get out of this episode:\nDiscussion on innovative CNS drug development on BioBreakthroughs podcast.\nLearn about Praxis' genetics-inspired approach to tackling complex brain diseases.\nSouza highlights the challenges and opportunities in CNS treatment, including the impactful EMBOLD and EMBRAVE studies.\nDiscover Praxis Precision Medicines' future prospects and their commitment to revolutionizing patient care in the CNS field.\n\nTo learn more about our guests and their companies:\nLinkedIn: https://www.linkedin.com/in/marcio-souza-2b02837/\nCompany LinkedIn: https://www.linkedin.com/company/praxis-precision-medicines-inc/\nWebsite: https://praxismedicines.com/\n\nOur sponsor for this episode are:\nSage Growth Partners https://sage-growth.com/\nBioBreakthroughs is part of the Slice of Healthcare podcast network:\nLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}